GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,905 Cr | ₹1,525 Cr | ₹1,326 Cr | ₹1,698 Cr | ₹1,355 Cr |
What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,905 Cr |
| Mar2024 | ₹1,525 Cr |
| Mar2023 | ₹1,326 Cr |
| Mar2022 | ₹1,698 Cr |
| Mar2021 | ₹1,355 Cr |
How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,905 Cr | 24.93 | |
| Mar2024 | ₹1,525 Cr | 14.97 | |
| Mar2023 | ₹1,326 Cr | -21.91 | |
| Mar2022 | ₹1,698 Cr | 25.38 | |
| Mar2021 | ₹1,355 Cr | - | |
Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,983.5 Cr | 2.2% | -6.1% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
-6.1% |
-15.2% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses